APA (7th ed.) Citation

D, Z., A, H., A, B., A, S., M, N., E, S., . . . F, O. (2022). Preclinical evaluation of FAP-2286 for fibroblast activation protein targeted radionuclide imaging and therapy. European journal of nuclear medicine and molecular imaging, 49(11), 3651. https://doi.org/10.1007/s00259-022-05842-5

Chicago Style (17th ed.) Citation

D, Zboralski, et al. "Preclinical Evaluation of FAP-2286 for Fibroblast Activation Protein Targeted Radionuclide Imaging and Therapy." European Journal of Nuclear Medicine and Molecular Imaging 49, no. 11 (2022): 3651. https://doi.org/10.1007/s00259-022-05842-5.

MLA (9th ed.) Citation

D, Zboralski, et al. "Preclinical Evaluation of FAP-2286 for Fibroblast Activation Protein Targeted Radionuclide Imaging and Therapy." European Journal of Nuclear Medicine and Molecular Imaging, vol. 49, no. 11, 2022, p. 3651, https://doi.org/10.1007/s00259-022-05842-5.